Henny Billett, MD
Hematology · Bronx, NYNPI 1689755001
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,155 of the $1,187 with a category attached, or 97.2%. New York Blood Center, Inc. accounts for 97.2% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $1,155, more than ten times the $20 reported in 2019. That places this record below the midpoint for hematology clinicians in NY, where the typical reported total is $619.
Across 3 payments — averaging $395.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- New York Blood Center, Inc.$1K
- Novartis$20
- Takeda Pharmaceuticals U.S.A., Inc.$13
Across 25 payments — averaging $11,774 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Global Blood Therapeutics, Inc.$271K
- Novartis$18K
- Janssen Research & Development, LLC$6K
What the payments were for
- Food & beverage$333%
- Education$1,15597%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| New York Blood Center, Inc. | 1 | $1,155 |
| Novartis | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$1,187 in reported general payments places this provider in the 50th percentile of 157 hematology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $40,219 |
| Tranexamic Acid | 13 | $1,194 |
| Warfarin Sodium | 21 | $74 |
Paid to pharmacies, not to this prescriber.
Other hematology in Bronx
- Ellen FriedmanBronx$18K
- Barry CollerNew York$7.9M
- Allyson OceanNew York$1.4M
- Ahmed SawasNew York$618K
- Jeffrey ZwickerNew York$561K
- Dan DouerNew York$477K
- Ran ReshefNew York$468K
- Faith DaviesNew York$307K
- Michael MauroNew York$229K
- Richard FurmanNew York$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.